ArticleMethods and protocols2025

Empagliflozin Repurposing for Lafora Disease: A Pilot Clinical Trial and Preclinical Investigation of Novel Therapeutic Targets.

Giuseppe d'Orsi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.